This is being filed to report the atrial septal defect requiring intervention.It was reported that the initial mitraclip procedure was performed on (b)(6) 2019, to treat functional mitral regurgitation (mr) with a grade of 4.One clip was implanted, reducing mr to 2.The patient returned at a later date with the mr increased to 4.A second procedure was performed on (b)(6) 2021.During preparation of the clip delivery system (cds), the clip could not be inverted therefore the device was not used.The second clip delivery system (cds) was advanced and placed on the mitral valve.Post deployment it was noted the clip appeared to be opened more than the previously implanted clip.The procedure was concluded with the mr reduced to 2.The atrial septal defect was closed with an occluder.There was no clinically significant delay in the procedure and no adverse patient sequela.No additional information was provided.
|
The device was not returned for analysis.In this case, there was no reported device malfunction associated with the steerable guide catheter.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on the information reviewed, a cause for the reported perforation could not be confirmed.The reported additional unexpected medical intervention was a result of case-specific circumstances.The reported patient effects of perforation, as listed in the mitraclip instructions for use (ifu), is a known possible complication associated with mitraclip procedures there is no indication of a product issue with respect to manufacture, design or labeling.
|